# Impact of transurethral resection of bladder tumors on sexual function and quality of life using ePROMs in patients with bladder cancer– a prospective cohort study

**Authors:** H.S. Menold, B. Gruene, J. Koenig, M. Lenhart, F. Waldbillig, K.F. Kowalewski, M.S. Michel, MC. Kriegmair, M. Neuberger, F. Wessels

PMC · DOI: 10.1007/s00345-025-05726-x · 2025-06-10

## TL;DR

This study shows that TURBT surgery significantly affects male sexual function and quality of life for up to a year, but not in female patients.

## Contribution

The study is the first to use ePROMs to assess sexual function and QoL in bladder cancer patients after TURBT.

## Key findings

- Male sexual function was significantly impaired at 3, 6, and 12 months post-TURBT.
- Age was the strongest factor affecting male sexual function and quality of life.
- Female patients did not show significant changes in sexual function or QoL after TURBT.

## Abstract

The impact of transurethral resection of bladder tumors (TURBT) on patients’ quality of life (QoL) and sexual function is underrepresented in the literature. Therefore, this study aimed to evaluate sexual function and QoL following TURBT, using electronic patient reported outcome questionnaires (ePROMs).

Patients undergoing TURBT were surveyed using a digital ePROM system (Heartbeat Medical). Sexual function and QoL were assessed using the Male/Female LUTS Sexual Function module (ICIQ-MLUTSsex/FLUTSsex) at 3, 6 and 12 months postoperatively and the EORTC QLQ-NMIBC 24. Linear mixed-effects models were used to identify influencing factors, adjusting for baseline. Repeated measures ANOVA tested differences in domain scores over time.

197 patients completed the survey, of whom 77% (n = 151) were men. Based on the ICIQ-MLUTSsex sexual function was significantly impaired at 3, 6 and 12-months postoperatively compared to baseline (p = 0.005; p = 0.004; p = 0.017). Age was the strongest factor for reduced male sexual function (ICIQ-MLUTSsex and QLQ-NMIBC24: p < 0.001). Subdomain analysis revealed negative effects on ejaculation (p = 0.044) and urinary symptoms (p = 0.031) up to 6 months. No differences were observed for the female population.

TURBT may result in long-term impairment of sexual function in male patients, whereas no such effect was observed in female patients within this cohort.

The online version contains supplementary material available at 10.1007/s00345-025-05726-x.

## Linked entities

- **Diseases:** bladder cancer (MONDO:0004986)

## Full-text entities

- **Diseases:** bladder cancer (MESH:D001749), impairment of sexual function (MESH:D012734), reduced male sexual function (MESH:D007172)
- **Chemicals:** ICIQ (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12152061/full.md

---
Source: https://tomesphere.com/paper/PMC12152061